FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2061585822> ?p ?o ?g. }

• W2061585822 endingPage "5142" @default.
• W2061585822 startingPage "5136" @default.
• W2061585822 abstract "Abstract Nelarabine (506U78) is a soluble pro-drug of 9-β-d-arabinofuranosylguanine (ara-G), a deoxyguanosine derivative. We treated 26 patients with T-cell acute lymphoblastic leukemia (T-ALL) and 13 with T-cell lymphoblastic lymphoma (T-LBL) with nelarabine. All patients were refractory to at least one multiagent regimen or had relapsed after achieving a complete remission. Nelarabine was administered on an alternate day schedule (days 1, 3, and 5) at 1.5 g/m2/day. Cycles were repeated every 22 days. The median age was 34 years (range, 16-66 years); 32 (82%) patients were male. The rate of complete remission was 31% (95% confidence interval [CI], 17%, 48%) and the overall response rate was 41% (95% CI, 26%, 58%). The principal toxicity was grade 3 or 4 neutropenia and thrombocytopenia, occurring in 37% and 26% of patients, respectively. There was only one grade 4 adverse event of the nervous system, which was a reversible depressed level of consciousness. The median disease-free survival (DFS) was 20 weeks (95% CI, 11, 56), and the median overall survival was 20 weeks (95% CI, 13, 36). The 1-year overall survival was 28% (95% CI, 15%, 43%). Nelarabine is well tolerated and has significant antitumor activity in relapsed or refractory T-ALL and T-LBL." @default.
• W2061585822 created "2016-06-24" @default.
• W2061585822 creator A5003889511 @default.
• W2061585822 creator A5007254355 @default.
• W2061585822 creator A5009941371 @default.
• W2061585822 creator A5035535476 @default.
• W2061585822 creator A5043668088 @default.
• W2061585822 creator A5056405520 @default.
• W2061585822 creator A5056482233 @default.
• W2061585822 creator A5068867603 @default.
• W2061585822 creator A5071023119 @default.
• W2061585822 creator A5082924494 @default.
• W2061585822 date "2007-06-15" @default.
• W2061585822 modified "2023-10-17" @default.
• W2061585822 title "Nelarabine induces complete remissions in adults with relapsed or refractory T-lineage acute lymphoblastic leukemia or lymphoblastic lymphoma: Cancer and Leukemia Group B study 19801" @default.
• W2061585822 cites W1913773793 @default.
• W2061585822 cites W1919339218 @default.
• W2061585822 cites W1932853631 @default.
• W2061585822 cites W1968390239 @default.
• W2061585822 cites W1969847547 @default.
• W2061585822 cites W1970473877 @default.
• W2061585822 cites W1984079088 @default.
• W2061585822 cites W1996468637 @default.
• W2061585822 cites W2049443129 @default.
• W2061585822 cites W2064276205 @default.
• W2061585822 cites W2115482777 @default.
• W2061585822 cites W2156377069 @default.
• W2061585822 cites W2316493963 @default.
• W2061585822 cites W255003803 @default.
• W2061585822 cites W2992077408 @default.
• W2061585822 cites W4247922423 @default.
• W2061585822 doi "https://doi.org/10.1182/blood-2006-11-056754" @default.
• W2061585822 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/1941786" @default.
• W2061585822 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/17344466" @default.
• W2061585822 hasPublicationYear "2007" @default.
• W2061585822 type Work @default.
• W2061585822 sameAs 2061585822 @default.
• W2061585822 citedByCount "256" @default.
• W2061585822 countsByYear W20615858222012 @default.
• W2061585822 countsByYear W20615858222013 @default.
• W2061585822 countsByYear W20615858222014 @default.
• W2061585822 countsByYear W20615858222015 @default.
• W2061585822 countsByYear W20615858222016 @default.
• W2061585822 countsByYear W20615858222017 @default.
• W2061585822 countsByYear W20615858222018 @default.
• W2061585822 countsByYear W20615858222019 @default.
• W2061585822 countsByYear W20615858222020 @default.
• W2061585822 countsByYear W20615858222021 @default.
• W2061585822 countsByYear W20615858222022 @default.
• W2061585822 countsByYear W20615858222023 @default.
• W2061585822 crossrefType "journal-article" @default.
• W2061585822 hasAuthorship W2061585822A5003889511 @default.
• W2061585822 hasAuthorship W2061585822A5007254355 @default.
• W2061585822 hasAuthorship W2061585822A5009941371 @default.
• W2061585822 hasAuthorship W2061585822A5035535476 @default.
• W2061585822 hasAuthorship W2061585822A5043668088 @default.
• W2061585822 hasAuthorship W2061585822A5056405520 @default.
• W2061585822 hasAuthorship W2061585822A5056482233 @default.
• W2061585822 hasAuthorship W2061585822A5068867603 @default.
• W2061585822 hasAuthorship W2061585822A5071023119 @default.
• W2061585822 hasAuthorship W2061585822A5082924494 @default.
• W2061585822 hasBestOaLocation W20615858221 @default.
• W2061585822 hasConcept C121332964 @default.
• W2061585822 hasConcept C126322002 @default.
• W2061585822 hasConcept C141071460 @default.
• W2061585822 hasConcept C142424586 @default.
• W2061585822 hasConcept C203014093 @default.
• W2061585822 hasConcept C2776090121 @default.
• W2061585822 hasConcept C2776694085 @default.
• W2061585822 hasConcept C2777063308 @default.
• W2061585822 hasConcept C2777478502 @default.
• W2061585822 hasConcept C2778461978 @default.
• W2061585822 hasConcept C2779338263 @default.
• W2061585822 hasConcept C2781107101 @default.
• W2061585822 hasConcept C2781413609 @default.
• W2061585822 hasConcept C2909962599 @default.
• W2061585822 hasConcept C71924100 @default.
• W2061585822 hasConcept C87355193 @default.
• W2061585822 hasConcept C8891405 @default.
• W2061585822 hasConcept C90924648 @default.
• W2061585822 hasConceptScore W2061585822C121332964 @default.
• W2061585822 hasConceptScore W2061585822C126322002 @default.
• W2061585822 hasConceptScore W2061585822C141071460 @default.
• W2061585822 hasConceptScore W2061585822C142424586 @default.
• W2061585822 hasConceptScore W2061585822C203014093 @default.
• W2061585822 hasConceptScore W2061585822C2776090121 @default.
• W2061585822 hasConceptScore W2061585822C2776694085 @default.
• W2061585822 hasConceptScore W2061585822C2777063308 @default.
• W2061585822 hasConceptScore W2061585822C2777478502 @default.
• W2061585822 hasConceptScore W2061585822C2778461978 @default.
• W2061585822 hasConceptScore W2061585822C2779338263 @default.
• W2061585822 hasConceptScore W2061585822C2781107101 @default.
• W2061585822 hasConceptScore W2061585822C2781413609 @default.
• W2061585822 hasConceptScore W2061585822C2909962599 @default.
• W2061585822 hasConceptScore W2061585822C71924100 @default.
• W2061585822 hasConceptScore W2061585822C87355193 @default.
• W2061585822 hasConceptScore W2061585822C8891405 @default.
• W2061585822 hasConceptScore W2061585822C90924648 @default.

• next